Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neovascularization associated with tendinopathy involves the aberrant growth of small blood vessels and accompanying nerves into normally hypovascular tendon tissue. This process is driven by factors such as increased expression of VEGF and matrix metalloproteinases (MMPs), contributing to extracellular matrix degradation, chronic pain, and further tendon degeneration. While neovessel detection by Doppler ultrasound is diagnostic, therapeutic targeting of neovessels or their drivers is experimental and carries potential risks.
Inhibition of angiogenesis (anti-VEGF); Vessel sclerosis/obliteration (sclerosing injections); Anti-inflammatory effects (corticosteroids)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neovascularization associated with tendinopathy.